109 related articles for article (PubMed ID: 22151005)
41. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.
Dineen R; Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Keevil BG; Tormey W; Smith D; Thompson CJ; McKenna MJ; Arlt W; Stewart PM; Agha A; Sherlock M
BMC Endocr Disord; 2020 Oct; 20(1):154. PubMed ID: 33036588
[TBL] [Abstract][Full Text] [Related]
42. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
[TBL] [Abstract][Full Text] [Related]
43. Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapy.
Ajmal A; McKean E; Sullivan S; Barkan A
Pituitary; 2018 Dec; 21(6):624-630. PubMed ID: 30349995
[TBL] [Abstract][Full Text] [Related]
44. Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism.
McConnell EM; Bell PM; Ennis C; Hadden DR; McCance DR; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2002 Feb; 56(2):195-201. PubMed ID: 11874410
[TBL] [Abstract][Full Text] [Related]
45. Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study.
Danilowicz K; Bruno OD; Manavela M; Gomez RM; Barkan A
Pituitary; 2008; 11(3):279-85. PubMed ID: 18459045
[TBL] [Abstract][Full Text] [Related]
46. Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism.
Li Voon Chong JS; Sen J; Johnson Z; Kyle G; MacFarlane IA
Clin Endocrinol (Oxf); 2001 Feb; 54(2):267-71. PubMed ID: 11207643
[TBL] [Abstract][Full Text] [Related]
47. Long-acting hydrocortisone for glucocorticoid replacement therapy.
Johannsson G; Filipsson H; Bergthorsdottir R; Lennernäs H; Skrtic S
Horm Res; 2007; 68 Suppl 5():182-8. PubMed ID: 18174742
[TBL] [Abstract][Full Text] [Related]
48. Growth hormone deficiency in treated acromegaly and active Cushing's syndrome.
Formenti AM; Maffezzoni F; Doga M; Mazziotti G; Giustina A
Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):79-90. PubMed ID: 28477735
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy.
McConnell EM; Bell PM; Hadden DR; McCance DR; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2001 May; 54(5):593-9. PubMed ID: 11380489
[TBL] [Abstract][Full Text] [Related]
50. Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCT.
Werumeus Buning J; Kootstra-Ros JE; Brummelman P; van den Berg G; van der Klauw M; Wolffenbuttel BH; van Beek AP; Dullaart RP
Eur J Clin Invest; 2016 May; 46(5):475-80. PubMed ID: 26999644
[TBL] [Abstract][Full Text] [Related]
51. The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients.
Ragnarsson O; Mattsson AF; Monson JP; Filipsson Nyström H; Åkerblad AC; Kołtowska-Häggström M; Johannsson G
Eur J Endocrinol; 2014 Nov; 171(5):571-9. PubMed ID: 25127712
[TBL] [Abstract][Full Text] [Related]
52. The clinical utility of alternative, less invasive sampling techniques in the assessment of oral hydrocortisone therapy in children and adolescents with hypopituitarism.
Maguire AM; Ambler GR; Moore B; Waite K; McLean M; Cowell CT
Eur J Endocrinol; 2007 Apr; 156(4):471-6. PubMed ID: 17389462
[TBL] [Abstract][Full Text] [Related]
53. Anterior pituitary hormone effects on hepatic functions in infants with congenital hypopituitarism.
Karnsakul W; Sawathiparnich P; Nimkarn S; Likitmaskul S; Santiprabhob J; Aanpreung P
Ann Hepatol; 2007; 6(2):97-103. PubMed ID: 17519832
[TBL] [Abstract][Full Text] [Related]
54. An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid.
Chikada N; Imaki T; Hotta M; Sato K; Takano K
Endocr J; 2004 Jun; 51(3):355-60. PubMed ID: 15256782
[TBL] [Abstract][Full Text] [Related]
55. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
Benson S; Neumann P; Unger N; Schedlowski M; Mann K; Elsenbruch S; Petersenn S
Eur J Endocrinol; 2012 Nov; 167(5):679-85. PubMed ID: 22930487
[TBL] [Abstract][Full Text] [Related]
56. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial.
Werumeus Buning J; van Faassen M; Brummelman P; Dullaart RP; van den Berg G; van der Klauw MM; Kerstens MN; Stegeman CA; Muller Kobold AC; Kema IP; Wolffenbuttel BH; van Beek AP
J Clin Endocrinol Metab; 2016 Oct; 101(10):3691-3699. PubMed ID: 27490921
[TBL] [Abstract][Full Text] [Related]
57. Thrombospondin-1 is a glucocorticoid responsive protein in humans.
Barclay JL; Petersons CJ; Keshvari S; Sorbello J; Mangelsdorf BL; Thompson CH; Prins JB; Burt MG; Whitehead JP; Inder WJ
Eur J Endocrinol; 2016 Feb; 174(2):193-201. PubMed ID: 26578641
[TBL] [Abstract][Full Text] [Related]
58. [Opioid Induced Pituitary Dysfunction].
Jonasdottir AI; Johannsson J; Kristjansson M; Benediktsson R
Laeknabladid; 2018 Jul; 104(7):347-349. PubMed ID: 29972136
[TBL] [Abstract][Full Text] [Related]
59. Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature.
Tiemensma J; Andela CD; Kaptein AA; Romijn JA; van der Mast RC; Biermasz NR; Pereira AM
Eur J Endocrinol; 2014 Aug; 171(2):171-82. PubMed ID: 24801589
[TBL] [Abstract][Full Text] [Related]
60. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
